Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ESPR

Esperion

$66.98

-0.14 (-0.21%)

06:37
01/05/18
01/05
06:37
01/05/18
06:37
Upgrade
Esperion rating change at BofA/Merrill »

Esperion upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$66.98

-0.14 (-0.21%)

06:14
01/05/18
01/05
06:14
01/05/18
06:14
Upgrade
Esperion rating change at BofA/Merrill »

Esperion upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ESPR

Esperion

$57.13

1.05 (1.87%)

07:17
12/14/17
12/14
07:17
12/14/17
07:17
Upgrade
Esperion rating change at Needham »

Esperion upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$57.13

1.05 (1.87%)

07:06
12/14/17
12/14
07:06
12/14/17
07:06
Upgrade
Esperion rating change at Needham »

Esperion upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$56.97

2.3 (4.21%)

06:12
12/11/17
12/11
06:12
12/11/17
06:12
Conference/Events
Esperion management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ESPR

Esperion

$56.51

0.7 (1.25%)

06:39
11/27/17
11/27
06:39
11/27/17
06:39
Conference/Events
Esperion management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ESPR

Esperion

$48.51

0.89 (1.87%)

08:09
11/07/17
11/07
08:09
11/07/17
08:09
Earnings
Breaking Earnings news story on Esperion »

Esperion reports Q3 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ESPR

Esperion

$48.51

0.89 (1.87%)

16:45
11/06/17
11/06
16:45
11/06/17
16:45
Hot Stocks
Esperion starts Phase 3 study for the Bempedoic Acid/Ezetimibe combination pill »

Esperion Therapeutic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Over a quarter ago
ESPR

Esperion

$52.98

-0.94 (-1.74%)

08:25
10/17/17
10/17
08:25
10/17/17
08:25
Conference/Events
Esperion to hold analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

ESPR

Esperion

$52.98

-0.94 (-1.74%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Esperion to hold analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.